Carboplatine

DRUG5 trials

Sponsors

Lymphoma Study Association, Institut Claudius Regaud, Central Hospital, Nancy, France, The Lymphoma Academic Research Organisation, Gustave Roussy, Cancer Campus, Grand Paris

Conditions

Germ Cell TumorsHodgkin DiseaseLymphoma, Large-Cell, DiffuseMedulloblastomaNSCLC (Advanced Non-small Cell Lung Cancer)

Phase 1

Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE

CompletedNCT02686346

The Lymphoma Academic Research OrganisationHodgkin Disease

Start: 2016-03-31End: 2021-07-12Updated: 2021-12-07

Phase 2

Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis

CompletedNCT00864318

Institut Claudius RegaudGerm Cell Tumors

Start: 2009-03-13End: 2020-10-05Updated: 2021-01-12

Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas

Central Hospital, Nancy, FranceMedulloblastoma

Start: 2013-04-10End: 2021-12-31Target: 97Updated: 2018-07-05

Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer

RecruitingNCT07001618

Gustave Roussy, Cancer Campus, Grand ParisNSCLC (Advanced Non-small Cell Lung Cancer)

Start: 2025-11-17End: 2032-09-01Target: 162Updated: 2026-04-03

Phase 3

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

CompletedNCT00137995

Lymphoma Study AssociationLymphoma, Large-Cell, Diffuse

Start: 2003-06-30End: 2008-10-31Updated: 2019-08-28

Related Papers

P+R‐ICE: PEMBROLIZUMAB IN COMBINATION WITH R‐ICE CHEMOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ‐ ONGOING TRIAL

Hematological Oncology2023-06-01

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study

Leukemia & lymphoma/Leukemia and lymphoma2022-08-179 citations

Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma

Blood Advances2022-01-1420 citations

Phase II trial of TI-CE high dose chemotherapy (HDCT) with drug monitoring for individual carboplatin dosing in patients with relapsed advanced germ cell tumors: A multicentric prospective GETUG trial.

Journal of Clinical Oncology2017-02-205 citations